Cardiometabolic and genetic factors in the progression of metabolic dysfunction-associated steatotic liver disease
T2DM, dyslipidemia and WC values are the determining factors in the development of cACLD in patients with MASLD. The <i>PNPLA3</i> I148M gene polymorphism has no leading importance for the development of the progressive course of MASLD in the studied cohort.
Authors
- V. P. Gomonova (ORCID: https://orcid.org/0000-0001-8159-9745)
- K. L. Raikhelson (ORCID: https://orcid.org/0000-0002-8821-6142)
Institutions
- St Petersburg University (RU)
Publication Details
- Journal
- Terapevticheskii arkhiv
- Published
- 2025-03-26
- DOI
- https://doi.org/10.26442/00403660.2025.02.203203
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00